The speaker says decisions about changing drug-discovery practices should depend substantially on what evidence can establish.

“exactly how things should change I think will depend a lot on what we actually can prove right is it the case you actually reach the point that you can get better results from a neural net than from actually running a clinical trial like we're not there but”